Tiny Nanoparticles Could Help Save Lives From a Deadly Blood Infection

Scientists have created tiny drug capsules called EONPs that may help treat sepsis, a deadly infection that kills millions of people every year. Sepsis happens when the immune system overreacts to an infection and starts damaging the body's own organs. Researchers tested EONPs in mice and found the capsules could calm harmful inflammation, protect organs like the lungs and kidneys, and restore healthy bacteria in the gut. The team hopes this discovery could one day lead to better treatments for very sick patients.

Macrophages are key immune cells that act like soldiers fighting infection, but in sepsis they get stuck in a harmful mode called M1. In M1 mode, macrophages release chemicals that hurt the body instead of helping it heal. Scientists want to switch them to M2 mode, which calms inflammation and supports recovery. EONPs were designed to do exactly that — flip macrophages from harmful to helpful.

The tiny capsule carries two medicines at once: one that blocks a pathway called STING, and one that slows a protein called DHODH. Both of these become too active during sepsis and make inflammation worse. By stopping both at the same time, EONPs work better than either medicine alone. The capsule also opens only inside inflamed tissue, so the drugs go right where they are needed.

One surprising result was what EONPs did to the bacteria in the guts of the mice. Sepsis upsets the balance of gut bacteria, allowing harmful types to take over. After treatment with EONPs, helpful bacteria like Akkermansia muciniphila became more common. A better balance of gut bacteria helped the body fight inflammation more effectively.

These healthy gut bacteria helped produce a chemical called 5-HIAA, which comes from the breakdown of tryptophan — an amino acid found in foods like turkey and eggs. The scientists found that 5-HIAA acted like a natural calming signal for the immune system. It helped push macrophages further into the helpful M2 mode. This surprising link between gut bacteria, brain chemistry, and immune cells is a key part of why EONPs work so well.

In mouse tests, septic mice given EONPs lived much longer than mice that got no treatment or only one of the two drugs. Their livers and kidneys stayed healthier, and they had less damage to their lungs and intestines. The treatment also reduced the dangerous flood of immune chemicals in the blood, called a cytokine storm. These results show a clear benefit from delivering both medicines together in one nanoparticle.